About us

Our mission

preventing renal failure after heart surgery

In Pleioflow, we develop and commercialize Innovative solutions for people fighting CardioVascular Disease.

We do it with Passion, Commitment and Dedication for the benefit of patients, Healthcare Systems and our Shareholders.

The problem

ACUTE KIDNEY FAILURE

Acute Kidney Injury (AKI) is often recognized late and can result in morbidity, mortality and increased cost of care.

PERCENTAGE OF PATIENTS
DEVELOPING ACUTE RENAL
FAILURE POSTOPERATIVELY
(600,000 AKI PATIENTS)

There Are More Than
2 MILLION PATIENTS
Around The World UNDERGOING
CARDIAC SURGERY
ON AN ANNUAL BASIS

PERCENTAGE OF PATIENTS
PERMANENTLY AFFECTED BY
RENAL FAILURE REQUIRING
LIFE-LONG DIALYSIS

4-6B $/year
TOTAL RENAL FAILURE COSTS ASSOCIATED WITH CARDIAC SURGERY

AVERAGE EXTRA COST OF CARE PER CARDIAC SURGERY AKI PATIENT

EXTRA COST ASSOCIATED WITH END STAGE RENAL FAILURE PER PATIENT

LENGTH OF STAY

2-3 times prolonged

HOSPITAL COSTS

2-3 times higher

RE-ADMISSIONS

2-3 times more
(in less than 30 days)

CHRONIC KIDNEY DISEASE

2-3 times worse

HOSPITAL MORTALITY

6-13 times higher

OUR PRODUCTS

THE SOLUTION PLEIOFLOW-RF

Pleioflow-RF is a percutaneous Flow Assist Device incorporating an Innovative, Advanced and Patented Technology. The Device is capable of augmenting the flow and pressure in any desired region of the Descending and Abdominal Aorta, likely increasing renal/mesenteric perfusion during Cardiopulmonary By Pass (CPB), and/or after myocardial Infarction (MI), thus possibly preventing Renal failure in both Cardiac Surgery and post-MI patients (in Clinical trials)

CHARACTERISTICS

  • Easy to use
  • Innovative and simple design
  • Old proven principle
  • Low Profile
  • Affordable, likely excellent clinical value for money
OUR PRODUCTS

THE SOLUTION PLEIOFLOW-HF

Pleioflow-HF is a minimally invasive blood flow assist device of a disruptive, innovative and patented technology featuring a self-expanding percutaneous catheter-mounted flow assist segment

CHARACTERISTICS

  • Easy to use
  • Innovative and simple design
  • Old proven principle
  • Low Profile
  • Affordable, likely excellent clinical value for money

easy to use &
Cost effective device

“Pleioflow Device may be characterised as a percutaneous LVAD. It is based on a radical modification of an olden proven principle of IAB devices, that may (remains to be clinically proven) significantly improve the current management of any patient with flow deprivation, requiring flow assist.  The device has a very low flow profile of just 8 French, it is easy to insert even in critically unstable patients,  and it has an affordable price“

– Dr. Constantinos Anagnostopoulos
CEO and Founder

CONTACT US

GET IN TOUCH

Have a question? We are here for you.

    PleioFlow UK LTD.

    51 Stanton Road, Stapenhill, Burton-On-Trent, Staffordshire, United Kingdom, DE15 9RP

    info@pleioflow.com

    PleioFlow Hellas SA.

    Peloponnesou 4 & Argolidos 2 Str., 145 64 Kifissia
    Athens, Greece

    +30 210 6209 866

    info@pleioflow.com